Physician profile
Dale W Stovall
NPI 1962592485
$590,427.80
in general payments reported to CMS, 2019-2025
31 companies · $114K in 2025
The $114K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115K · 2020: $46K · 2021: $105K · 2022: $67K · 2023: $87K · 2024: $56K · 2025: $114K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $171K · Travel and Lodging: $30K · Honoraria: $24K · Consulting Fee: $19K · Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $171,332.50 |
| Travel and Lodging | $29,987.96 |
| Honoraria | $24,080.00 |
| Consulting Fee | $19,208.00 |
| Food and Beverage | $12,031.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $249,791.63 | 2019-2024 | Orilissa |
| Mayne Pharma Commercial LLC | $228,674.72 | 2021-2025 | |
| Myovant Sciences INC. | $39,780.66 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $31,790.86 | 2019-2025 | |
| Astellas Pharma US INC | $14,955.55 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $10,710.74 | 2023-2025 | Myfembree |
| Pfizer INC. | $5,852.20 | 2021-2022 | |
| Organon LLC | $3,727.87 | 2021-2025 | Jada System |
| Shield Therapeutics INC | $2,077.94 | 2023-2024 | Accrufer |
| Merck Sharp & Dohme LLC | $1,399.73 | 2019 | |
| Fujirebio Diagnostics, Incorporated | $724.94 | 2022 | |
| Davol INC. | $160.27 | 2023 | Arista Ah Flexitip |
| Coopersurgical, INC. | $114.05 | 2024-2025 | Stripper, Endosee |
| Gen-Probe, INC. | $106.65 | 2019 | |
| Ethicon US, LLC | $98.40 | 2021-2023 | Vistaseal |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $53.85 | 2019-2020 | |
| Myovant Sciences Gmbh | $49.44 | 2022 | |
| Kci USA, INC. | $45.55 | 2019-2023 | Prevena, Abthera, V.A.C. Veraflo |
| Evofem Biosciences, INC. | $44.48 | 2022-2024 | |
| Hologic Sales and Service, LLC | $38.83 | 2021-2022 | |
| Mallinckrodt Enterprises LLC | $33.80 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $31.23 | 2019-2021 | |
| Astellas Pharma Global Development | $29.25 | 2024 | Veozah |
| Meditrina | $20.85 | 2023 | |
| Mission Pharmacal Company | $20.72 | 2020 | |
| Exeltis, USA INC. | $20.68 | 2025 | Slynd |
| Astrazeneca Pharmaceuticals Lp | $20.13 | 2024 | Andexxa |
| Smith+Nephew, INC. | $15.91 | 2024 | Stravix |
| Minerva Surgical, INC | $13.80 | 2022 | |
| Mallinckrodt Hospital Products INC. | $12.18 | 2020 | |
| Channel Medsystems, INC. | $10.89 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dale Stovall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.